Literature DB >> 9755881

Chitosan and its use as a pharmaceutical excipient.

L Illum1.   

Abstract

Chitosan has been investigated as an excipient in the pharmaceutical industry, to be used in direct tablet compression, as a tablet disintegrant, for the production of controlled release solid dosage forms or for the improvement of drug dissolution. Chitosan has, compared to traditional excipients, been shown to have superior characteristics and especially flexibility in its use. Furthermore, chitosan has been used for production of controlled release implant systems for delivery of hormones over extended periods of time. Lately, the transmucosal absorption promoting characteristics of chitosan has been exploited especially for nasal and oral delivery of polar drugs to include peptides and proteins and for vaccine delivery. These properties, together with the very safe toxicity profile, makes chitosan an exciting and promising excipient for the pharmaceutical industry for present and future applications.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9755881     DOI: 10.1023/a:1011929016601

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  21 in total

1.  [Usage of chitosan as a pharmaceutical material effectiveness as an additional additives of sodium alginate].

Authors:  T Miyazaki; T Komuro; C Yomota; S Okada
Journal:  Eisei Shikenjo Hokoku       Date:  1990

2.  Chitosans as absorption enhancers for poorly absorbable drugs. 1: Influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (Caco-2) cells.

Authors:  N G Schipper; K M Vårum; P Artursson
Journal:  Pharm Res       Date:  1996-11       Impact factor: 4.200

3.  Chitosan as a nasal delivery system: the effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers.

Authors:  T J Aspden; J D Mason; N S Jones; J Lowe; O Skaugrud; L Illum
Journal:  J Pharm Sci       Date:  1997-04       Impact factor: 3.534

4.  Chitosan microcapsules as controlled release systems for insulin.

Authors:  K Aiedeh; E Gianasi; I Orienti; V Zecchi
Journal:  J Microencapsul       Date:  1997 Sep-Oct       Impact factor: 3.142

5.  Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2).

Authors:  P Artursson; T Lindmark; S S Davis; L Illum
Journal:  Pharm Res       Date:  1994-09       Impact factor: 4.200

6.  Preparation of a prolonged release tablet of aspirin with chitosan.

Authors:  Y Kawashima; S Y Lin; A Kasai; T Handa; H Takenaka
Journal:  Chem Pharm Bull (Tokyo)       Date:  1985-05       Impact factor: 1.645

7.  The use of chitin and chitosan as drug carriers.

Authors:  S Miyazaki; K Ishii; T Nadai
Journal:  Chem Pharm Bull (Tokyo)       Date:  1981-10       Impact factor: 1.645

8.  Directly compressed tablets containing chitin or chitosan in addition to lactose or potato starch.

Authors:  Y Sawayanagi; N Nambu; T Nagai
Journal:  Chem Pharm Bull (Tokyo)       Date:  1982-08       Impact factor: 1.645

9.  Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines.

Authors:  P Calvo; C Remuñan-López; J L Vila-Jato; M J Alonso
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

10.  Glutaraldehyde cross-linked chitosan microspheres as a long acting biodegradable drug delivery vehicle: studies on the in vitro release of mitoxantrone and in vivo degradation of microspheres in rat muscle.

Authors:  S R Jameela; A Jayakrishnan
Journal:  Biomaterials       Date:  1995-07       Impact factor: 12.479

View more
  146 in total

Review 1.  Bioadhesion: new possibilities for drug administration?

Authors:  J Woodley
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

2.  Extrusion/spheronization of pectin-based formulations. II. Effect of additive concentration in the granulation liquid.

Authors:  T Tho; P Kleinebudde; S A Sande
Journal:  AAPS PharmSciTech       Date:  2001-12-03       Impact factor: 3.246

Review 3.  Absorption enhancers for nasal drug delivery.

Authors:  Stanley S Davis; Lisbeth Illum
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 4.  Application of in situ polymerization for design and development of oral drug delivery systems.

Authors:  Ndidi Ngwuluka
Journal:  AAPS PharmSciTech       Date:  2010-11-11       Impact factor: 3.246

5.  Pharmacokinetics and pharmacodynamics of nasally delivered midazolam.

Authors:  Manuel Haschke; Katja Suter; Sarah Hofmann; Robert Witschi; Johannes Fröhlich; Georgios Imanidis; Jürgen Drewe; Thomas A Briellmann; Franz E Dussy; Stephan Krähenbühl; Christian Surber
Journal:  Br J Clin Pharmacol       Date:  2010-06       Impact factor: 4.335

Review 6.  Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents.

Authors:  Anumita Chaudhury; Surajit Das
Journal:  AAPS PharmSciTech       Date:  2010-12-11       Impact factor: 3.246

7.  Long-term stability of chitosan-based polyplexes.

Authors:  Kristine Romøren; Astrid Aaberge; Gro Smistad; Beate J Thu; Oystein Evensen
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

8.  Studies on effect of pH on cross-linking of chitosan with sodium tripolyphosphate: a technical note.

Authors:  Devika R Bhumkar; Varsha B Pokharkar
Journal:  AAPS PharmSciTech       Date:  2006-06-02       Impact factor: 3.246

9.  Alginate/chitosan nanoparticles are effective for oral insulin delivery.

Authors:  B Sarmento; A Ribeiro; F Veiga; P Sampaio; R Neufeld; D Ferreira
Journal:  Pharm Res       Date:  2007-06-19       Impact factor: 4.200

10.  Effect of PEG and water-soluble chitosan coating on moxifloxacin-loaded PLGA long-circulating nanoparticles.

Authors:  Sanaul Mustafa; V Kusum Devi; Roopa S Pai
Journal:  Drug Deliv Transl Res       Date:  2017-02       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.